1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine

C22H25N7O2 — CID 139515203

IUPAC1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine
SMILESCc1ccc(-c2noc(C3CCCN(C)C3)n2)cc1NNOc1cnc2ccccn12
InChIInChI=1S/C22H25N7O2/c1-15-8-9-16(21-24-22(31-26-21)17-6-5-10-28(2)14-17)12-18(15)25-27-30-20-13-23-19-7-3-4-11-29(19)20/h3-4,7-9,11-13,17,25,27H,5-6,10,14H2,1-2H3
InChIKeyWUXRETQGPULJMF-UHFFFAOYSA-N
MW419.49 g/mol
LogP3.41
Rot. Bonds6

About 1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine

1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine (PubChem CID 139515203) has the molecular formula C22H25N7O2 and a molecular weight of 419.49 g/mol. Its IUPAC name is 1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine.

Molecular Properties

Compound Name1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine
PubChem CID139515203
Molecular FormulaC22H25N7O2
Molecular Weight419.49 g/mol
Exact Mass419.21
IUPAC Name1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine
SMILESCc1ccc(-c2noc(C3CCCN(C)C3)n2)cc1NNOc1cnc2ccccn12
InChIInChI=1S/C22H25N7O2/c1-15-8-9-16(21-24-22(31-26-21)17-6-5-10-28(2)14-17)12-18(15)25-27-30-20-13-23-19-7-3-4-11-29(19)20/h3-4,7-9,11-13,17,25,27H,5-6,10,14H2,1-2H3
InChIKeyWUXRETQGPULJMF-UHFFFAOYSA-N
XLogP3.41
TPSA92.75 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds6
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500419.49
LogP ≤ 53.41
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine?
The IUPAC name of 1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine (CID 139515203) is 1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine.
What is the SMILES notation for 1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine?
The canonical SMILES for 1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine is Cc1ccc(-c2noc(C3CCCN(C)C3)n2)cc1NNOc1cnc2ccccn12.
What is the InChIKey of 1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine?
The InChIKey is WUXRETQGPULJMF-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H25N7O2/c1-15-8-9-16(21-24-22(31-26-21)17-6-5-10-28(2)14-17)12-18(15)25-27-30-20-13-23-19-7-3-4-11-29(19)20/h3-4,7-9,11-13,17,25,27H,5-6,10,14H2,1-2H3.
What are the key properties of 1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine?
1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine has a molecular weight of 419.49 g/mol, XLogP of 3.41, 6 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 1-imidazo[1,2-a]pyridin-3-yloxy-2-[2-methyl-5-[5-(1-methylpiperidin-3-yl)-1,2,4-oxadiazol-3-yl]phenyl]hydrazine is sourced from PubChem (CID 139515203), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).